nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Mometasone—systemic scleroderma	0.285	0.647	CrCtD
Flunisolide—Prednisone—systemic scleroderma	0.155	0.353	CrCtD
Flunisolide—NR3C1—Mometasone—systemic scleroderma	0.121	0.705	CbGbCtD
Flunisolide—NR3C1—Prednisone—systemic scleroderma	0.0384	0.224	CbGbCtD
Flunisolide—Fluticasone furoate—Mometasone—systemic scleroderma	0.0108	0.0343	CrCrCtD
Flunisolide—Flumethasone Pivalate—Mometasone—systemic scleroderma	0.00973	0.0308	CrCrCtD
Flunisolide—Halobetasol Propionate—Mometasone—systemic scleroderma	0.00942	0.0298	CrCrCtD
Flunisolide—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00942	0.0298	CrCrCtD
Flunisolide—Difluprednate—Mometasone—systemic scleroderma	0.00942	0.0298	CrCrCtD
Flunisolide—Prednicarbate—Mometasone—systemic scleroderma	0.00886	0.028	CrCrCtD
Flunisolide—Clocortolone—Mometasone—systemic scleroderma	0.00886	0.028	CrCrCtD
Flunisolide—Fluocinonide—Mometasone—systemic scleroderma	0.00886	0.028	CrCrCtD
Flunisolide—Fluocortolone—Mometasone—systemic scleroderma	0.0086	0.0272	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.00837	0.0265	CrCrCtD
Flunisolide—Alclometasone—Mometasone—systemic scleroderma	0.00837	0.0265	CrCrCtD
Flunisolide—Amcinonide—Mometasone—systemic scleroderma	0.00814	0.0258	CrCrCtD
Flunisolide—Budesonide—Mometasone—systemic scleroderma	0.00814	0.0258	CrCrCtD
Flunisolide—Desonide—Mometasone—systemic scleroderma	0.00793	0.0251	CrCrCtD
Flunisolide—Prednisone—Mometasone—systemic scleroderma	0.00793	0.0251	CrCrCtD
Flunisolide—Diflorasone—Mometasone—systemic scleroderma	0.00793	0.0251	CrCrCtD
Flunisolide—Paramethasone—Mometasone—systemic scleroderma	0.00773	0.0245	CrCrCtD
Flunisolide—Desoximetasone—Mometasone—systemic scleroderma	0.00754	0.0239	CrCrCtD
Flunisolide—Triamcinolone—Mometasone—systemic scleroderma	0.00737	0.0233	CrCrCtD
Flunisolide—Fluorometholone—Mometasone—systemic scleroderma	0.00737	0.0233	CrCrCtD
Flunisolide—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.00737	0.0233	CrCrCtD
Flunisolide—Loteprednol—Mometasone—systemic scleroderma	0.00737	0.0233	CrCrCtD
Flunisolide—Dexamethasone—Mometasone—systemic scleroderma	0.0072	0.0228	CrCrCtD
Flunisolide—Rimexolone—Mometasone—systemic scleroderma	0.0072	0.0228	CrCrCtD
Flunisolide—Betamethasone—Mometasone—systemic scleroderma	0.0072	0.0228	CrCrCtD
Flunisolide—Methylprednisolone—Mometasone—systemic scleroderma	0.00688	0.0218	CrCrCtD
Flunisolide—Prednisolone—Mometasone—systemic scleroderma	0.00674	0.0213	CrCrCtD
Flunisolide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00671	0.0392	CbGbCtD
Flunisolide—Hydrocortisone—Mometasone—systemic scleroderma	0.00647	0.0205	CrCrCtD
Flunisolide—Ciclesonide—Prednisone—systemic scleroderma	0.00614	0.0194	CrCrCtD
Flunisolide—CYP3A4—Prednisone—systemic scleroderma	0.00536	0.0313	CbGbCtD
Flunisolide—Prednicarbate—Prednisone—systemic scleroderma	0.00483	0.0153	CrCrCtD
Flunisolide—Fluocortolone—Prednisone—systemic scleroderma	0.00469	0.0148	CrCrCtD
Flunisolide—Alclometasone—Prednisone—systemic scleroderma	0.00456	0.0144	CrCrCtD
Flunisolide—Budesonide—Prednisone—systemic scleroderma	0.00444	0.014	CrCrCtD
Flunisolide—Amcinonide—Prednisone—systemic scleroderma	0.00444	0.014	CrCrCtD
Flunisolide—Diflorasone—Prednisone—systemic scleroderma	0.00432	0.0137	CrCrCtD
Flunisolide—Desonide—Prednisone—systemic scleroderma	0.00432	0.0137	CrCrCtD
Flunisolide—Paramethasone—Prednisone—systemic scleroderma	0.00422	0.0133	CrCrCtD
Flunisolide—Desoximetasone—Prednisone—systemic scleroderma	0.00411	0.013	CrCrCtD
Flunisolide—Triamcinolone—Prednisone—systemic scleroderma	0.00402	0.0127	CrCrCtD
Flunisolide—Fluorometholone—Prednisone—systemic scleroderma	0.00402	0.0127	CrCrCtD
Flunisolide—Mometasone—Prednisone—systemic scleroderma	0.00402	0.0127	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00402	0.0127	CrCrCtD
Flunisolide—Loteprednol—Prednisone—systemic scleroderma	0.00402	0.0127	CrCrCtD
Flunisolide—Dexamethasone—Prednisone—systemic scleroderma	0.00392	0.0124	CrCrCtD
Flunisolide—Rimexolone—Prednisone—systemic scleroderma	0.00392	0.0124	CrCrCtD
Flunisolide—Betamethasone—Prednisone—systemic scleroderma	0.00392	0.0124	CrCrCtD
Flunisolide—Methylprednisolone—Prednisone—systemic scleroderma	0.00375	0.0119	CrCrCtD
Flunisolide—Prednisolone—Prednisone—systemic scleroderma	0.00367	0.0116	CrCrCtD
Flunisolide—Hydrocortisone—Prednisone—systemic scleroderma	0.00353	0.0112	CrCrCtD
Flunisolide—Hyperhidrosis—Leflunomide—systemic scleroderma	6.98e-05	0.000967	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	6.97e-05	0.000965	CcSEcCtD
Flunisolide—Abdominal pain—Captopril—systemic scleroderma	6.93e-05	0.00096	CcSEcCtD
Flunisolide—Body temperature increased—Captopril—systemic scleroderma	6.93e-05	0.00096	CcSEcCtD
Flunisolide—Oedema—Mycophenolic acid—systemic scleroderma	6.89e-05	0.000955	CcSEcCtD
Flunisolide—Nausea—Pentoxifylline—systemic scleroderma	6.87e-05	0.000952	CcSEcCtD
Flunisolide—Chills—Mycophenolate mofetil—systemic scleroderma	6.87e-05	0.000952	CcSEcCtD
Flunisolide—Malaise—Lisinopril—systemic scleroderma	6.86e-05	0.00095	CcSEcCtD
Flunisolide—Infection—Mycophenolic acid—systemic scleroderma	6.85e-05	0.000948	CcSEcCtD
Flunisolide—Vertigo—Lisinopril—systemic scleroderma	6.83e-05	0.000947	CcSEcCtD
Flunisolide—Diarrhoea—Mometasone—systemic scleroderma	6.83e-05	0.000946	CcSEcCtD
Flunisolide—Syncope—Lisinopril—systemic scleroderma	6.82e-05	0.000945	CcSEcCtD
Flunisolide—Shock—Mycophenolic acid—systemic scleroderma	6.78e-05	0.000939	CcSEcCtD
Flunisolide—Tachycardia—Mycophenolic acid—systemic scleroderma	6.73e-05	0.000932	CcSEcCtD
Flunisolide—Palpitations—Lisinopril—systemic scleroderma	6.72e-05	0.000931	CcSEcCtD
Flunisolide—Loss of consciousness—Lisinopril—systemic scleroderma	6.68e-05	0.000926	CcSEcCtD
Flunisolide—Malnutrition—Mycophenolate mofetil—systemic scleroderma	6.66e-05	0.000923	CcSEcCtD
Flunisolide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	6.66e-05	0.000923	CcSEcCtD
Flunisolide—Cough—Lisinopril—systemic scleroderma	6.64e-05	0.000919	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	6.58e-05	0.000912	CcSEcCtD
Flunisolide—Insomnia—Leflunomide—systemic scleroderma	6.53e-05	0.000905	CcSEcCtD
Flunisolide—Abdominal distension—Prednisone—systemic scleroderma	6.53e-05	0.000904	CcSEcCtD
Flunisolide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	6.53e-05	0.000904	CcSEcCtD
Flunisolide—Chest pain—Lisinopril—systemic scleroderma	6.47e-05	0.000897	CcSEcCtD
Flunisolide—Myalgia—Lisinopril—systemic scleroderma	6.47e-05	0.000897	CcSEcCtD
Flunisolide—Anxiety—Lisinopril—systemic scleroderma	6.45e-05	0.000894	CcSEcCtD
Flunisolide—Back pain—Mycophenolate mofetil—systemic scleroderma	6.45e-05	0.000893	CcSEcCtD
Flunisolide—Dyspnoea—Leflunomide—systemic scleroderma	6.44e-05	0.000892	CcSEcCtD
Flunisolide—Discomfort—Lisinopril—systemic scleroderma	6.4e-05	0.000886	CcSEcCtD
Flunisolide—Dyspepsia—Leflunomide—systemic scleroderma	6.36e-05	0.000881	CcSEcCtD
Flunisolide—Vomiting—Mometasone—systemic scleroderma	6.34e-05	0.000879	CcSEcCtD
Flunisolide—Feeling abnormal—Azathioprine—systemic scleroderma	6.3e-05	0.000873	CcSEcCtD
Flunisolide—Rash—Mometasone—systemic scleroderma	6.29e-05	0.000872	CcSEcCtD
Flunisolide—Asthenia—Captopril—systemic scleroderma	6.29e-05	0.000871	CcSEcCtD
Flunisolide—Dermatitis—Mometasone—systemic scleroderma	6.29e-05	0.000871	CcSEcCtD
Flunisolide—Decreased appetite—Leflunomide—systemic scleroderma	6.28e-05	0.00087	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	6.28e-05	0.00087	CcSEcCtD
Flunisolide—Gastrointestinal pain—Azathioprine—systemic scleroderma	6.25e-05	0.000867	CcSEcCtD
Flunisolide—Headache—Mometasone—systemic scleroderma	6.25e-05	0.000866	CcSEcCtD
Flunisolide—Tremor—Mycophenolate mofetil—systemic scleroderma	6.24e-05	0.000865	CcSEcCtD
Flunisolide—Insomnia—Mycophenolic acid—systemic scleroderma	6.23e-05	0.000863	CcSEcCtD
Flunisolide—Fatigue—Leflunomide—systemic scleroderma	6.23e-05	0.000863	CcSEcCtD
Flunisolide—Oedema—Lisinopril—systemic scleroderma	6.21e-05	0.00086	CcSEcCtD
Flunisolide—Pruritus—Captopril—systemic scleroderma	6.2e-05	0.000859	CcSEcCtD
Flunisolide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	6.18e-05	0.000857	CcSEcCtD
Flunisolide—Constipation—Leflunomide—systemic scleroderma	6.18e-05	0.000856	CcSEcCtD
Flunisolide—Pain—Leflunomide—systemic scleroderma	6.18e-05	0.000856	CcSEcCtD
Flunisolide—Infection—Lisinopril—systemic scleroderma	6.17e-05	0.000854	CcSEcCtD
Flunisolide—Dyspnoea—Mycophenolic acid—systemic scleroderma	6.14e-05	0.000851	CcSEcCtD
Flunisolide—Agitation—Mycophenolate mofetil—systemic scleroderma	6.12e-05	0.000848	CcSEcCtD
Flunisolide—Shock—Lisinopril—systemic scleroderma	6.11e-05	0.000846	CcSEcCtD
Flunisolide—Dyspepsia—Mycophenolic acid—systemic scleroderma	6.07e-05	0.00084	CcSEcCtD
Flunisolide—Tachycardia—Lisinopril—systemic scleroderma	6.06e-05	0.000839	CcSEcCtD
Flunisolide—Abdominal pain—Azathioprine—systemic scleroderma	6.05e-05	0.000838	CcSEcCtD
Flunisolide—Body temperature increased—Azathioprine—systemic scleroderma	6.05e-05	0.000838	CcSEcCtD
Flunisolide—Malaise—Mycophenolate mofetil—systemic scleroderma	6.01e-05	0.000833	CcSEcCtD
Flunisolide—Hyperhidrosis—Lisinopril—systemic scleroderma	6e-05	0.000831	CcSEcCtD
Flunisolide—Diarrhoea—Captopril—systemic scleroderma	6e-05	0.000831	CcSEcCtD
Flunisolide—Decreased appetite—Mycophenolic acid—systemic scleroderma	5.99e-05	0.00083	CcSEcCtD
Flunisolide—Vertigo—Mycophenolate mofetil—systemic scleroderma	5.99e-05	0.000829	CcSEcCtD
Flunisolide—Irritability—Methotrexate—systemic scleroderma	5.98e-05	0.000829	CcSEcCtD
Flunisolide—Syncope—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.000828	CcSEcCtD
Flunisolide—Feeling abnormal—Leflunomide—systemic scleroderma	5.95e-05	0.000825	CcSEcCtD
Flunisolide—Fatigue—Mycophenolic acid—systemic scleroderma	5.94e-05	0.000823	CcSEcCtD
Flunisolide—Nausea—Mometasone—systemic scleroderma	5.93e-05	0.000821	CcSEcCtD
Flunisolide—Gastrointestinal pain—Leflunomide—systemic scleroderma	5.91e-05	0.000818	CcSEcCtD
Flunisolide—Weight increased—Prednisone—systemic scleroderma	5.9e-05	0.000817	CcSEcCtD
Flunisolide—Pain—Mycophenolic acid—systemic scleroderma	5.89e-05	0.000816	CcSEcCtD
Flunisolide—Constipation—Mycophenolic acid—systemic scleroderma	5.89e-05	0.000816	CcSEcCtD
Flunisolide—Palpitations—Mycophenolate mofetil—systemic scleroderma	5.89e-05	0.000816	CcSEcCtD
Flunisolide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	5.86e-05	0.000811	CcSEcCtD
Flunisolide—Cough—Mycophenolate mofetil—systemic scleroderma	5.81e-05	0.000806	CcSEcCtD
Flunisolide—Dizziness—Captopril—systemic scleroderma	5.8e-05	0.000803	CcSEcCtD
Flunisolide—Hypertension—Mycophenolate mofetil—systemic scleroderma	5.75e-05	0.000797	CcSEcCtD
Flunisolide—Urticaria—Leflunomide—systemic scleroderma	5.74e-05	0.000795	CcSEcCtD
Flunisolide—Abdominal pain—Leflunomide—systemic scleroderma	5.71e-05	0.000791	CcSEcCtD
Flunisolide—Body temperature increased—Leflunomide—systemic scleroderma	5.71e-05	0.000791	CcSEcCtD
Flunisolide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	5.68e-05	0.000787	CcSEcCtD
Flunisolide—Myalgia—Mycophenolate mofetil—systemic scleroderma	5.67e-05	0.000786	CcSEcCtD
Flunisolide—Chest pain—Mycophenolate mofetil—systemic scleroderma	5.67e-05	0.000786	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	5.66e-05	0.000783	CcSEcCtD
Flunisolide—Anxiety—Mycophenolate mofetil—systemic scleroderma	5.65e-05	0.000783	CcSEcCtD
Flunisolide—Hypersensitivity—Azathioprine—systemic scleroderma	5.64e-05	0.000781	CcSEcCtD
Flunisolide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	5.64e-05	0.000781	CcSEcCtD
Flunisolide—Insomnia—Lisinopril—systemic scleroderma	5.61e-05	0.000778	CcSEcCtD
Flunisolide—Discomfort—Mycophenolate mofetil—systemic scleroderma	5.61e-05	0.000777	CcSEcCtD
Flunisolide—Vomiting—Captopril—systemic scleroderma	5.57e-05	0.000772	CcSEcCtD
Flunisolide—Dyspnoea—Lisinopril—systemic scleroderma	5.53e-05	0.000767	CcSEcCtD
Flunisolide—Rash—Captopril—systemic scleroderma	5.53e-05	0.000766	CcSEcCtD
Flunisolide—Dermatitis—Captopril—systemic scleroderma	5.52e-05	0.000765	CcSEcCtD
Flunisolide—Headache—Captopril—systemic scleroderma	5.49e-05	0.000761	CcSEcCtD
Flunisolide—Dyspepsia—Lisinopril—systemic scleroderma	5.46e-05	0.000757	CcSEcCtD
Flunisolide—Abdominal pain—Mycophenolic acid—systemic scleroderma	5.45e-05	0.000755	CcSEcCtD
Flunisolide—Body temperature increased—Mycophenolic acid—systemic scleroderma	5.45e-05	0.000755	CcSEcCtD
Flunisolide—Oedema—Mycophenolate mofetil—systemic scleroderma	5.44e-05	0.000753	CcSEcCtD
Flunisolide—Infection—Mycophenolate mofetil—systemic scleroderma	5.4e-05	0.000749	CcSEcCtD
Flunisolide—Decreased appetite—Lisinopril—systemic scleroderma	5.4e-05	0.000748	CcSEcCtD
Flunisolide—Fatigue—Lisinopril—systemic scleroderma	5.35e-05	0.000741	CcSEcCtD
Flunisolide—Shock—Mycophenolate mofetil—systemic scleroderma	5.35e-05	0.000741	CcSEcCtD
Flunisolide—Hypersensitivity—Leflunomide—systemic scleroderma	5.32e-05	0.000737	CcSEcCtD
Flunisolide—Constipation—Lisinopril—systemic scleroderma	5.31e-05	0.000735	CcSEcCtD
Flunisolide—Pain—Lisinopril—systemic scleroderma	5.31e-05	0.000735	CcSEcCtD
Flunisolide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	5.31e-05	0.000735	CcSEcCtD
Flunisolide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.000728	CcSEcCtD
Flunisolide—Diarrhoea—Azathioprine—systemic scleroderma	5.23e-05	0.000725	CcSEcCtD
Flunisolide—Nausea—Captopril—systemic scleroderma	5.21e-05	0.000721	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—systemic scleroderma	5.19e-05	0.00072	CcSEcCtD
Flunisolide—Asthenia—Leflunomide—systemic scleroderma	5.18e-05	0.000718	CcSEcCtD
Flunisolide—Feeling abnormal—Lisinopril—systemic scleroderma	5.11e-05	0.000709	CcSEcCtD
Flunisolide—Pruritus—Leflunomide—systemic scleroderma	5.11e-05	0.000708	CcSEcCtD
Flunisolide—Gastrointestinal pain—Lisinopril—systemic scleroderma	5.08e-05	0.000703	CcSEcCtD
Flunisolide—Dizziness—Azathioprine—systemic scleroderma	5.06e-05	0.000701	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—systemic scleroderma	5.04e-05	0.000698	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	4.95e-05	0.000686	CcSEcCtD
Flunisolide—Asthenia—Mycophenolic acid—systemic scleroderma	4.94e-05	0.000685	CcSEcCtD
Flunisolide—Diarrhoea—Leflunomide—systemic scleroderma	4.94e-05	0.000685	CcSEcCtD
Flunisolide—Urticaria—Lisinopril—systemic scleroderma	4.93e-05	0.000683	CcSEcCtD
Flunisolide—Insomnia—Mycophenolate mofetil—systemic scleroderma	4.92e-05	0.000681	CcSEcCtD
Flunisolide—Abdominal pain—Lisinopril—systemic scleroderma	4.91e-05	0.00068	CcSEcCtD
Flunisolide—Body temperature increased—Lisinopril—systemic scleroderma	4.91e-05	0.00068	CcSEcCtD
Flunisolide—Pruritus—Mycophenolic acid—systemic scleroderma	4.88e-05	0.000675	CcSEcCtD
Flunisolide—Vomiting—Azathioprine—systemic scleroderma	4.86e-05	0.000674	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—systemic scleroderma	4.86e-05	0.000673	CcSEcCtD
Flunisolide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	4.85e-05	0.000672	CcSEcCtD
Flunisolide—Rash—Azathioprine—systemic scleroderma	4.82e-05	0.000668	CcSEcCtD
Flunisolide—Dermatitis—Azathioprine—systemic scleroderma	4.82e-05	0.000668	CcSEcCtD
Flunisolide—Headache—Azathioprine—systemic scleroderma	4.79e-05	0.000664	CcSEcCtD
Flunisolide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	4.79e-05	0.000663	CcSEcCtD
Flunisolide—Dizziness—Leflunomide—systemic scleroderma	4.78e-05	0.000662	CcSEcCtD
Flunisolide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	4.73e-05	0.000655	CcSEcCtD
Flunisolide—Diarrhoea—Mycophenolic acid—systemic scleroderma	4.72e-05	0.000653	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—systemic scleroderma	4.71e-05	0.000652	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—systemic scleroderma	4.7e-05	0.000651	CcSEcCtD
Flunisolide—Constipation—Mycophenolate mofetil—systemic scleroderma	4.65e-05	0.000644	CcSEcCtD
Flunisolide—Pain—Mycophenolate mofetil—systemic scleroderma	4.65e-05	0.000644	CcSEcCtD
Flunisolide—Sweating—Methotrexate—systemic scleroderma	4.63e-05	0.000642	CcSEcCtD
Flunisolide—Vomiting—Leflunomide—systemic scleroderma	4.59e-05	0.000636	CcSEcCtD
Flunisolide—Hypersensitivity—Lisinopril—systemic scleroderma	4.57e-05	0.000634	CcSEcCtD
Flunisolide—Dizziness—Mycophenolic acid—systemic scleroderma	4.56e-05	0.000631	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—systemic scleroderma	4.56e-05	0.000631	CcSEcCtD
Flunisolide—Rash—Leflunomide—systemic scleroderma	4.55e-05	0.000631	CcSEcCtD
Flunisolide—Dermatitis—Leflunomide—systemic scleroderma	4.55e-05	0.00063	CcSEcCtD
Flunisolide—Nausea—Azathioprine—systemic scleroderma	4.54e-05	0.000629	CcSEcCtD
Flunisolide—Headache—Leflunomide—systemic scleroderma	4.53e-05	0.000627	CcSEcCtD
Flunisolide—Malnutrition—Prednisone—systemic scleroderma	4.52e-05	0.000626	CcSEcCtD
Flunisolide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	4.48e-05	0.000621	CcSEcCtD
Flunisolide—Asthenia—Lisinopril—systemic scleroderma	4.45e-05	0.000617	CcSEcCtD
Flunisolide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	4.45e-05	0.000616	CcSEcCtD
Flunisolide—Pruritus—Lisinopril—systemic scleroderma	4.39e-05	0.000608	CcSEcCtD
Flunisolide—Vomiting—Mycophenolic acid—systemic scleroderma	4.38e-05	0.000607	CcSEcCtD
Flunisolide—Rash—Mycophenolic acid—systemic scleroderma	4.34e-05	0.000602	CcSEcCtD
Flunisolide—Dermatitis—Mycophenolic acid—systemic scleroderma	4.34e-05	0.000601	CcSEcCtD
Flunisolide—Urticaria—Mycophenolate mofetil—systemic scleroderma	4.32e-05	0.000599	CcSEcCtD
Flunisolide—Headache—Mycophenolic acid—systemic scleroderma	4.32e-05	0.000598	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—systemic scleroderma	4.3e-05	0.000596	CcSEcCtD
Flunisolide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	4.3e-05	0.000596	CcSEcCtD
Flunisolide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	4.3e-05	0.000596	CcSEcCtD
Flunisolide—Nausea—Leflunomide—systemic scleroderma	4.29e-05	0.000594	CcSEcCtD
Flunisolide—Vision blurred—Prednisone—systemic scleroderma	4.26e-05	0.00059	CcSEcCtD
Flunisolide—Diarrhoea—Lisinopril—systemic scleroderma	4.25e-05	0.000588	CcSEcCtD
Flunisolide—Ill-defined disorder—Prednisone—systemic scleroderma	4.19e-05	0.000581	CcSEcCtD
Flunisolide—Agitation—Prednisone—systemic scleroderma	4.15e-05	0.000575	CcSEcCtD
Flunisolide—Dizziness—Lisinopril—systemic scleroderma	4.1e-05	0.000569	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—systemic scleroderma	4.1e-05	0.000568	CcSEcCtD
Flunisolide—Nausea—Mycophenolic acid—systemic scleroderma	4.09e-05	0.000567	CcSEcCtD
Flunisolide—Malaise—Prednisone—systemic scleroderma	4.07e-05	0.000564	CcSEcCtD
Flunisolide—Vertigo—Prednisone—systemic scleroderma	4.06e-05	0.000562	CcSEcCtD
Flunisolide—Syncope—Prednisone—systemic scleroderma	4.05e-05	0.000561	CcSEcCtD
Flunisolide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	4.01e-05	0.000555	CcSEcCtD
Flunisolide—Loss of consciousness—Prednisone—systemic scleroderma	3.97e-05	0.00055	CcSEcCtD
Flunisolide—Vomiting—Lisinopril—systemic scleroderma	3.95e-05	0.000547	CcSEcCtD
Flunisolide—Rash—Lisinopril—systemic scleroderma	3.91e-05	0.000542	CcSEcCtD
Flunisolide—Dermatitis—Lisinopril—systemic scleroderma	3.91e-05	0.000542	CcSEcCtD
Flunisolide—Asthenia—Mycophenolate mofetil—systemic scleroderma	3.9e-05	0.000541	CcSEcCtD
Flunisolide—Hypertension—Prednisone—systemic scleroderma	3.9e-05	0.00054	CcSEcCtD
Flunisolide—Chills—Methotrexate—systemic scleroderma	3.89e-05	0.000539	CcSEcCtD
Flunisolide—Headache—Lisinopril—systemic scleroderma	3.89e-05	0.000539	CcSEcCtD
Flunisolide—Pruritus—Mycophenolate mofetil—systemic scleroderma	3.85e-05	0.000533	CcSEcCtD
Flunisolide—Myalgia—Prednisone—systemic scleroderma	3.85e-05	0.000533	CcSEcCtD
Flunisolide—Anxiety—Prednisone—systemic scleroderma	3.83e-05	0.000531	CcSEcCtD
Flunisolide—Discomfort—Prednisone—systemic scleroderma	3.8e-05	0.000526	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—systemic scleroderma	3.77e-05	0.000523	CcSEcCtD
Flunisolide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	3.72e-05	0.000516	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—systemic scleroderma	3.7e-05	0.000512	CcSEcCtD
Flunisolide—Nausea—Lisinopril—systemic scleroderma	3.69e-05	0.000511	CcSEcCtD
Flunisolide—Oedema—Prednisone—systemic scleroderma	3.69e-05	0.000511	CcSEcCtD
Flunisolide—Infection—Prednisone—systemic scleroderma	3.66e-05	0.000507	CcSEcCtD
Flunisolide—Back pain—Methotrexate—systemic scleroderma	3.65e-05	0.000506	CcSEcCtD
Flunisolide—Shock—Prednisone—systemic scleroderma	3.63e-05	0.000502	CcSEcCtD
Flunisolide—Tachycardia—Prednisone—systemic scleroderma	3.6e-05	0.000498	CcSEcCtD
Flunisolide—Dizziness—Mycophenolate mofetil—systemic scleroderma	3.6e-05	0.000498	CcSEcCtD
Flunisolide—Hyperhidrosis—Prednisone—systemic scleroderma	3.56e-05	0.000494	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—systemic scleroderma	3.56e-05	0.000493	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—systemic scleroderma	3.5e-05	0.000485	CcSEcCtD
Flunisolide—Vomiting—Mycophenolate mofetil—systemic scleroderma	3.46e-05	0.000479	CcSEcCtD
Flunisolide—Rash—Mycophenolate mofetil—systemic scleroderma	3.43e-05	0.000475	CcSEcCtD
Flunisolide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.43e-05	0.000475	CcSEcCtD
Flunisolide—Headache—Mycophenolate mofetil—systemic scleroderma	3.41e-05	0.000472	CcSEcCtD
Flunisolide—Malaise—Methotrexate—systemic scleroderma	3.4e-05	0.000472	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—systemic scleroderma	3.39e-05	0.00047	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	3.36e-05	0.000465	CcSEcCtD
Flunisolide—Insomnia—Prednisone—systemic scleroderma	3.33e-05	0.000462	CcSEcCtD
Flunisolide—Cough—Methotrexate—systemic scleroderma	3.29e-05	0.000456	CcSEcCtD
Flunisolide—Dyspepsia—Prednisone—systemic scleroderma	3.24e-05	0.00045	CcSEcCtD
Flunisolide—Nausea—Mycophenolate mofetil—systemic scleroderma	3.23e-05	0.000448	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—systemic scleroderma	3.21e-05	0.000445	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—systemic scleroderma	3.21e-05	0.000445	CcSEcCtD
Flunisolide—Decreased appetite—Prednisone—systemic scleroderma	3.2e-05	0.000444	CcSEcCtD
Flunisolide—Fatigue—Prednisone—systemic scleroderma	3.18e-05	0.00044	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—systemic scleroderma	3.18e-05	0.00044	CcSEcCtD
Flunisolide—Constipation—Prednisone—systemic scleroderma	3.15e-05	0.000437	CcSEcCtD
Flunisolide—Infection—Methotrexate—systemic scleroderma	3.06e-05	0.000424	CcSEcCtD
Flunisolide—Feeling abnormal—Prednisone—systemic scleroderma	3.04e-05	0.000421	CcSEcCtD
Flunisolide—Gastrointestinal pain—Prednisone—systemic scleroderma	3.01e-05	0.000418	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—systemic scleroderma	2.98e-05	0.000413	CcSEcCtD
Flunisolide—Urticaria—Prednisone—systemic scleroderma	2.93e-05	0.000406	CcSEcCtD
Flunisolide—Abdominal pain—Prednisone—systemic scleroderma	2.91e-05	0.000404	CcSEcCtD
Flunisolide—Body temperature increased—Prednisone—systemic scleroderma	2.91e-05	0.000404	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	2.81e-05	0.000389	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—systemic scleroderma	2.79e-05	0.000386	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—systemic scleroderma	2.75e-05	0.000381	CcSEcCtD
Flunisolide—Hypersensitivity—Prednisone—systemic scleroderma	2.72e-05	0.000376	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—systemic scleroderma	2.71e-05	0.000376	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—systemic scleroderma	2.68e-05	0.000371	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—systemic scleroderma	2.66e-05	0.000368	CcSEcCtD
Flunisolide—Asthenia—Prednisone—systemic scleroderma	2.64e-05	0.000366	CcSEcCtD
Flunisolide—Pain—Methotrexate—systemic scleroderma	2.63e-05	0.000365	CcSEcCtD
Flunisolide—Pruritus—Prednisone—systemic scleroderma	2.61e-05	0.000361	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—systemic scleroderma	2.54e-05	0.000352	CcSEcCtD
Flunisolide—Diarrhoea—Prednisone—systemic scleroderma	2.52e-05	0.000349	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—systemic scleroderma	2.52e-05	0.000349	CcSEcCtD
Flunisolide—Urticaria—Methotrexate—systemic scleroderma	2.45e-05	0.000339	CcSEcCtD
Flunisolide—Dizziness—Prednisone—systemic scleroderma	2.44e-05	0.000338	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—systemic scleroderma	2.44e-05	0.000337	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—systemic scleroderma	2.44e-05	0.000337	CcSEcCtD
Flunisolide—Vomiting—Prednisone—systemic scleroderma	2.34e-05	0.000325	CcSEcCtD
Flunisolide—Rash—Prednisone—systemic scleroderma	2.32e-05	0.000322	CcSEcCtD
Flunisolide—Dermatitis—Prednisone—systemic scleroderma	2.32e-05	0.000322	CcSEcCtD
Flunisolide—Headache—Prednisone—systemic scleroderma	2.31e-05	0.00032	CcSEcCtD
Flunisolide—Hypersensitivity—Methotrexate—systemic scleroderma	2.27e-05	0.000314	CcSEcCtD
Flunisolide—Asthenia—Methotrexate—systemic scleroderma	2.21e-05	0.000306	CcSEcCtD
Flunisolide—Nausea—Prednisone—systemic scleroderma	2.19e-05	0.000303	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—systemic scleroderma	2.18e-05	0.000302	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—systemic scleroderma	2.11e-05	0.000292	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—systemic scleroderma	2.04e-05	0.000282	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—systemic scleroderma	1.96e-05	0.000271	CcSEcCtD
Flunisolide—Rash—Methotrexate—systemic scleroderma	1.94e-05	0.000269	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—systemic scleroderma	1.94e-05	0.000269	CcSEcCtD
Flunisolide—Headache—Methotrexate—systemic scleroderma	1.93e-05	0.000267	CcSEcCtD
Flunisolide—Nausea—Methotrexate—systemic scleroderma	1.83e-05	0.000254	CcSEcCtD
